Concomitant intra-aortic balloon pump and veno-arterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Issue 6 (June 2023)

• Record Type: Journal Article
• Authors: Arafat, Amr A; Almedimigh, Abdulmalik A; Algarni, Khaled D; Ismail, Huda H; Pragliola, Claudio; Adam, Adam I; AlBarrak, Mohammed; Osman, Ahmed; Albabtain, Monirah A; Tantawy, Tarek M
• Is Part Of: International journal of artificial organs. Volume 46:Issue 6(2023)
• Page Start: 384
• Page End: 389
• Publication Date: 2023-06
• Subjects: Intra-aortic balloon pump -- extracorporeal membrane oxygenation -- postcardiotomy cardiogenic shock; Artificial organs -- Periodicals; 617.956
• DOI: 10.1177/03913988231170890
• Languages: English
• ISSNs: 0391-3988

Abstract

We aimed to compare the outcomes of ECMO with and without IABP for postcardiotomy cardiogenic shock. The study included 103 patients who needed ECMO for postcardiotomy cardiogenic shock. Patients were grouped according to the use of IABP into ECMO without IABP ( n = 43) and ECMO with IABP ( n = 60). The study endpoints were hospital complications, successful weaning, and survival. Patients with IABP had lower preoperative ejection fraction ( p = 0.002). There was no difference in stroke ( p = 0.97), limb ischemic ( p = 0.32), and duration of ICU stay ( p = 0.11) between groups. Successful weaning was non-significantly higher with IABP (36 (60%) vs 19 (44.19%); p = 0.11). Predictors of successful weaning were inversely related to the high pre-ECMO lactate levels (OR: 0.89; p = 0.01), active endocarditis (OR: 0.06; p = 0.02), older age (OR: 0.95; p = 0.02), and aortic valve replacement (OR: 0.26; p = 0.04). There was no difference in survival between groups ( p = 0.80). Our study did not support the routine use of IABP during ECMO support.